Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Deregulation of the imprinted DLK1-DIO3 locus ncRNAs is associated with replicative senescence of human adipose-derived stem cells

  • Garcia-Lopez, Silvia
  • Albo-Castellanos, Carmen
  • Urdinguio, Rocio G
  • Canon, Susana
  • Sanchez-Cabo, Fatima
  • Martínez-Serrano, Alberto
  • Fraga, Mario F
  • Bernad, Antonio
BACKGROUND: Human adult adipose-derived stem cells (hADSCs) have become the most promising cell source for regenerative medicine. However the prolonged ex vivo expansion periods required to obtain the necessary therapeutic dose promotes progressive senescence, with the concomitant reduction of their therapeutic potential. AIM AND SCOPE: A better understanding of the determinants of hADSC senescence is needed to improve biosafety while preserving therapeutic efficiency. Here, we investigated the association between deregulation of the imprinted DLK1-DIO3 region and replicative senescence in hADSC cultures. METHODS: We compared hADSC cultures at short (PS) and prolonged (PL) passages, both in standard and low [O2] (21 and 3%, respectively), in relation to replicative senescence. hADSCs were evaluated for expression alterations in the DLK1-DIO3 region on chromosome 14q32, and particularly in its main miRNA cluster. RESULTS: Comparison of hADSCs cultured at PL or PS surprisingly showed a quite significant fraction (69%) of upregulated miRNAs in PL cultures mapping to the imprinted 14q32 locus, the largest miRNA cluster described in the genome. In agreement, expression of the lncRNA MEG3 (Maternally Expressed 3; Meg3/Gtl2), cultured at 21 and 3% [O2], was also significantly higher in PL than in PS passages. During hADSC replicative senescence the AcK16H4 activating mark was found to be significantly associated with the deregulation of the entire DLK1-DIO3 locus, with a secondary regulatory role for the methylation of DMR regions. CONCLUSION: A direct relationship between DLK1-DIO3 deregulation and replicative senescence of hADSCs is reported, involving upregulation of a very significant fraction of its largest miRNA cluster (14q32.31), paralleled by the progressive overexpression of the lncRNA MEG3, which plays a central role in the regulation of Dlk1/Dio3 activation status in mice.
Repisalud
Publication Artículo científico (JournalArticle)

CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretome

  • Toran, Jose Luis
  • Aguilar, Susana
  • Lopez, Juan Antonio
  • Torroja, Carlos
  • Quintana, Juan A.
  • Santiago, Cesar
  • Abad, José Luis
  • Gomes-Alves, Patricia
  • Gonzalez, Andres
  • Bernal, Juan Antonio
  • Jimenez-Borreguero, Luis J.
  • Alves, Paula Marques
  • R-Borlado, Luis
  • Vazquez, Jesus
  • Bernad, Antonio
Studies in recent years have established that the principal effects in cardiac cell therapy are associated with paracrine/autocrine factors. We combined several complementary techniques to define human cardiac progenitor cell (CPC) secretome constituted by 914 proteins/genes; 51% of these are associated with the exosomal compartment. To define the set of proteins specifically or highly differentially secreted by CPC, we compared human mesenchymal stem cells and dermal fibroblasts; the study defined a group of growth factors, cytokines and chemokines expressed at high to medium levels by CPC. Among them, IL-1, GROa (CXCL1), CXCL6 (GCP2) and IL-8 are examples whose expression was confirmed by most techniques used. ELISA showed that CXCL6 is significantly overexpressed in CPC conditioned medium (CM) (18- to 26-fold) and western blot confirmed expression of its receptors CXCR1 and CXCR2. Addition of anti-CXCL6 completely abolished migration in CPC-CM compared with anti-CXCR2, which promoted partial inhibition, and anti-CXCR1, which was inefficient. Anti-CXCL6 also significantly inhibited CPC CM angiogenic activity. In vivo evaluation also supported a relevant role for angiogenesis. Altogether, these results suggest a notable angiogenic potential in CPC-CM and identify CXCL6 as an important paracrine factor for CPC that signals mainly through CXCR2.
Repisalud
Publication Artículo científico (JournalArticle)

Exploring analytical proteomics platforms toward the definition of human cardiac stem cells receptome

  • Gomes-Alves, Patrícia
  • Serra, Margarida
  • Brito, Catarina
  • R-Borlado, Luis
  • Lopez, Juan Antonio
  • Vazquez, Jesus
  • Carrondo, Manuel J T
  • Bernad, Antonio
  • Alves, Paula M
Human cardiac stem cells (hCSC) express a portfolio of plasma membrane receptors that are involved in the regulatory auto/paracrine feedback loop mechanism of activation of these cells, and consequently contribute to myocardial regeneration. In order to attain a comprehensive description of hCSC receptome and overcoming the inability demonstrated by other technologies applied in receptor identification, mainly due to the transmembrane nature, high hydrophobic character and relative low concentration of these proteins, we have exploited and improved a proteomics workflow. This approach was based on the enrichment of hCSC plasma membrane fraction and addition of prefractionation steps prior to MS analysis. More than 100 plasma membrane receptors were identified. The data reported herein constitute a valuable source of information to further understand cardiac stem cells activation mechanisms and the subsequent cardiac repair process. All MS data have been deposited in the ProteomeXchange with identifier PXD001117 (http://proteomecentral.proteomexchange.org/dataset/PXD001117).
Repisalud
Publication Artículo científico (JournalArticle)

Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization

  • Toran, Jose Luis
  • Lopez, Juan Antonio
  • Gomes-Alves, Patricia
  • Aguilar, Susana
  • Torroja, Carlos
  • Trevisan-Herraz, Marco
  • Moscoso, Isabel
  • Sebastião, Maria João
  • Serra, Margarida
  • Brito, Catarina
  • Cruz, Francisco Miguel
  • Sepulveda, Juan Carlos
  • Abad, José Luis
  • Galan-Arriola, Carlos
  • Ibáñez, Borja
  • Martinez, Fernando
  • Fernández, María Eugenia
  • Fernández-Avilés, Francisco
  • Palacios, Itziar
  • R-Borlado, Luis
  • Vazquez, Jesus
  • Alves, Paula M
  • Bernad, Antonio
Adult cardiac progenitor/stem cells (CPC/CSC) are multipotent resident populations involved in cardiac homeostasis and heart repair. Assisted by complementary RNAseq analysis, we defined the fraction of the CPC proteome associable with specific functions by comparison with human bone marrow mesenchymal stem cells (MSC), the reference population for cell therapy, and human dermal fibroblasts (HDF), as a distant reference. Label-free proteomic analysis identified 526 proteins expressed differentially in CPC. iTRAQ analysis confirmed differential expression of a substantial proportion of those proteins in CPC relative to MSC, and systems biology analysis defined a clear overrepresentation of several categories related to enhanced angiogenic potential. The CPC plasma membrane compartment comprised 1,595 proteins, including a minimal signature of 167 proteins preferentially or exclusively expressed by CPC. CDH5 (VE-cadherin),  OX2G (OX-2 membrane glycoprotein; CD200), GPR4 (G protein-coupled receptor 4), CACNG7 (calcium voltage-gated channel auxiliary subunit gamma 7) and F11R (F11 receptor; junctional adhesion molecule A; JAM-A; CD321) were selected for validation. Their differential expression was confirmed both in expanded CPC batches and in early stages of isolation, particularly when compared against cardiac fibroblasts. Among them, GPR4 demonstrated the highest discrimination capacity between all cell lineages analyzed.
Repisalud
Publication Artículo científico (JournalArticle)

Comparative proteomic analysis of nuclear and cytoplasmic compartments in human cardiac progenitor cells.

  • Albericio, Guillermo
  • Aguilar, Susana
  • Torán, Jose Luis
  • Yañez, Rosa
  • López, Juan Antonio
  • Vazquez, Jesus
  • Mora, Carmen
  • Bernad, Antonio
Clinical trials evaluating cardiac progenitor cells (CPC) demonstrated feasibility and safety, but no clear functional benefits. Therefore a deeper understanding of CPC biology is warranted to inform strategies capable to enhance their therapeutic potential. Here we have defined, using a label-free proteomic approach, the differential cytoplasmic and nuclear compartments of human CPC (hCPC). Global analysis of cytoplasmic repertoire in hCPC suggested an important hypoxia response capacity and active collagen metabolism. In addition, comparative analysis of the nuclear protein compartment identified a significant regulation of a small number of proteins in hCPC versus human mesenchymal stem cells (hMSC). Two proteins significantly upregulated in the hCPC nuclear compartment, IL1A and IMP3, showed also a parallel increase in mRNA expression in hCPC versus hMSC, and were studied further. IL1A, subjected to an important post-transcriptional regulation, was demonstrated to act as a dual-function cytokine with a plausible role in apoptosis regulation. The knockdown of the mRNA binding protein (IMP3) did not negatively impact hCPC viability, but reduced their proliferation and migration capacity. Analysis of a panel of putative candidate genes identified HMGA2 and PTPRF as IMP3 targets in hCPC. Therefore, they are potentially involved in hCPC proliferation/migration regulation.
Repisalud
Publication Artículo científico (JournalArticle)

miR-300 mediates Bmi1 function and regulates differentiation in primitive cardiac progenitors

  • Cruz, Francisco Miguel
  • Tome, Maria
  • Bernal, Juan Antonio
  • Bernad, Antonio
B lymphoma Mo-MLV insertion region 1 (Bmi1) is a polycomb-family transcriptional factor critical for self-renewal in many adult stem cells and human neoplasia. We sought to identify microRNAs regulated by Bmi1 that could play a role in multipotent cardiac progenitor cell (CPC) decisions. We found that miR-300, a poorly characterized microRNA mapping in the Dlk1-Dio3 microRNA cluster, was positively regulated by Bmi1 in CPCs. Forced expression of miR-300 in CPCs promoted an improved stemness signature with a significant increase in Oct4 levels, a reduction in senescence progression and an enhanced proliferative status via p19 activation and inhibition of p16 accumulation. Endothelial and cardiogenic differentiation were clearly compromised by sustained miR-300 expression. Additionally, RNA and protein analysis revealed a significant reduction in key cardiac transcription factors, including Nkx2.5 and Tbx5. Collectively, these results suggest that some functions attributed to Bmi1 are due to induction of miR-300, which decreases the cardiogenic differentiation potential of multipotent CPCs in vitro and promotes self-renewal.
Repisalud
Publication Artículo científico (JournalArticle)

Cardiac Bmi1(+) cells contribute to myocardial renewal in the murine adult heart

  • Valiente-Alandi, I
  • Albo-Castellanos, Carmen
  • Herrero, Diego
  • Arza, Elvira
  • Garcia-Gomez, Maria
  • Segovia, Jose Carlos
  • Capecchi, Mario
  • Bernad, Antonio
Introduction: The mammalian adult heart maintains a continuous, low cardiomyocyte turnover rate throughout life. Although many cardiac stem cell populations have been studied, the natural source for homeostatic repair has not yet been defined. The Polycomb protein BMI1 is the most representative marker of mouse adult stem cell systems. We have evaluated the relevance and role of cardiac Bmi1(+) cells in cardiac physiological homeostasis. Methods: Bmi1(CreER/+); Rosa26(YFP/+) (Bmi1-YFP) mice were used for lineage tracing strategy. After tamoxifen (TM) induction, yellow fluorescent protein (YFP) is expressed under the control of Rosa26 regulatory sequences in Bmi1(+) cells. These cells and their progeny were tracked by FACS, immunofluorescence and RT-qPCR techniques from 5 days to 1 year. Results: FACS analysis of non-cardiomyocyte compartment from TM-induced Bmi1-YFP mice showed a Bmi1 (+)-expressing cardiac progenitor cell (Bmi1-CPC: B-CPC) population, SCA-1 antigen-positive (95.9 +/- 0.4 \%) that expresses some stemness-associated genes. B-CPC were also able to differentiate in vitro to the three main cardiac lineages. Pulse-chase analysis showed that B-CPC remained quite stable for extended periods (up to 1 year), which suggests that this Bmi1(+) population contains cardiac progenitors with substantial self-maintenance potential. Specific immunostaining of Bmi1-YFP hearts serial sections 5 days post-TM induction indicated broad distribution of B-CPC, which were detected in variably sized clusters, although no YFP+ cardiomyocytes (CM) were detected at this time. Between 2 to 12 months after TM induction, YFP+ CM were clearly identified (3 +/- 0.6 \% to 6.7 +/- 1.3 \%) by immunohistochemistry of serial sections and by flow cytometry of total freshly isolated CM. B-CPC also contributed to endothelial and smooth muscle (SM) lineages in vivo. Conclusions: High Bmi1 expression identifies a non-cardiomyocyte resident cardiac population (B-CPC) that contributes to the main lineages of the heart in vitro and in vivo.
Dehesa. Repositorio Institucional de la Universidad de Extremadura
Publication Tesis doctoral (DoctoralThesis)

Desarrollo y estudio del potencial inmunomodulador de tres novedosas estrategias para la aplicación de la terapia celular

  • Blázquez Durán, Rebeca
La terapia celular ha emergido en los últimos años como una nueva herramienta terapéutica para el tratamiento de diversas patologías. Sin embargo, la vía y tipo de administración de estas terapias son factores enormemente condicionantes para la correcta implantación del producto terapéutico y, por tanto, para su eficacia. En este sentido, es necesario el desarrollo de métodos y vías de administración alternativos que aseguren viabilidad y la correcta implantación de las células madre para conseguir la optimización de estas terapias. Esta tesis doctoral plantea estrategias alternativas para favorecer la implantación y aumentar el efecto terapéutico de las células madre adultas. Cada una de estas estrategias constituye un bloque con entidad propia que se desarrolla a lo largo de los diferentes apartados de este trabajo. La primera estrategia se centra en el uso combinado de las células madre mesenquimales (Mesenchymal Stem Cells, MSCs) con materiales quirúrgicos para favorecer la implantación y la actividad biológica de las células. La segunda estrategia aborda una nueva vía de administración en el contexto de la terapia celular para el tratamiento de lesiones de origen cardiovascular. En concreto, las células madre adultas son administradas por vía intrapericárdica, evaluando su biodistribución y actividad inmunomoduladora en un modelo de animal grande. Por último, para la tercera estrategia se evalúa la actividad inmunomoduladora de exosomas derivados de MSCs, y se realiza una comparativa de diferentes metodologías de aislamiento de dichas vesículas para su extrapolación y aplicación en el entorno clínico., In the recent years, stem cell therapy has emerged as a novel therapeutic tool for the treatment of a wide range of diseases. The administration route has a significant impact on the success of these therapies as it determines the correct implantation of the therapeutic product as well as its effectiveness. In this sense, the evaluation of new approaches, alternative implantation routes and techniques is urgently needed. This PhD work analyses different strategies to improve the implantation and the therapeutic effect of adult stem cells. The results of these strategies are discussed along the different sections of this thesis. The first strategy was focused in the combination of mesenchymal stem cells (Mesenchymal Stem Cells (MSCs) and surgical materials to enhance the implantation and biological activity of MSCs. The second strategy addresses an innovative administration route in the context of cardiovascular cell therapy. Concretely, adult stem cells were intrapericardially administered, evaluating their bio-distribution and immunomodulatory activity in a large animal model. Finally, the immunomodulatory activity of MSCs-derived exosomes was evaluated and different isolation methods were assessed for their extrapolation and application in the clinical context., Este trabajo ha sido financiado en parte por la Junta de Extremadura, el Fondo Social Europeo y los Fondos FEDER a través de las ayudas concedidas a Rebeca Blázquez (TE12066) y Javier García (TA13042 e IBI3123), así como por la ayuda a grupos catalogados de la Junta de Extremadura (GR15175), las ayudas de Redes temáticas de investigación cooperativa en salud (DR12/0042/0025 a Francisco Miguel Sánchez Margallo y Claudia Báez), el Séptimo Programa Marco Europeo (FP7-HEALTH-2009-1.4-3 242038) y por el centro de Cirugía de Mínima Invasión.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Polμ deficiency increases resistance to oxidative damage and delays liver aging

  • Escudero, Beatriz
  • Lucas, Daniel
  • Albo, Carmen
  • Dhup, Suveera
  • Bacher, Jeff W.
  • Sánchez, Aránzazu
  • Fernández, Margarita
  • Rivera Torres, José
  • Carmona, Rosa M.
  • Fuster, Encarnación
  • Carreiro, Candelas
  • Bernad, Raquel
  • González, Manuel A.
  • Andrés, Vicente
  • Blanco, Luis
  • Roche, Enrique
  • Fabregat Romero, Isabel
  • Samper, Enrique
  • Bernad, Antonio
Polμ is an error-prone PolX polymerase that contributes to classical NHEJ DNA repair. Mice lacking Polμ (Polμ−/−) show altered hematopoiesis homeostasis and DSB repair and a more pronounced nucleolytic resection of some V(D)J junctions. We previously showed that Polμ−/− mice have increased learning capacity at old ages, suggesting delayed brain aging. Here we investigated the effect of Polμ−/− deficiency on liver aging. We found that old Polμ−/− mice (>20 month) have greater liver regenerative capacity compared with wt animals. Old Polμ−/− liver showed reduced genomic instability and increased apoptosis resistance. However, Polμ−/− mice did not show an extended life span and other organs (e.g., heart) aged normally. Our results suggest that Polμ deficiency activates transcriptional networks that reduce constitutive apoptosis, leading to enhanced liver repair at old age.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization

  • Torán, José Luis
  • López, Juan Antonio
  • Gomes-Alves, Patricia
  • Aguilar, Susana
  • Torroja, Carlos
  • Trevisan-Herraz, Marco
  • Moscoso, Isabel
  • Sebastião, Maria João
  • Serra, Margarida
  • Brito, Catarina
  • Cruz, Francisco Miguel
  • Sepúlveda, Juan Carlos
  • Abad, José Luis
  • Galán-Arriola, Carlos
  • Ibáñez, Borja
  • Martínez, Fernando
  • Fernández, María Eugenia
  • Fernández-Avilés, Francisco
  • Palacios, Itziar
  • Borlado, Luis R.
  • Vázquez, Jesús
  • Alves, Paula M.
  • Bernad, Antonio
© The Author(s) 2019., Adult cardiac progenitor/stem cells (CPC/CSC) are multipotent resident populations involved in cardiac homeostasis and heart repair. Assisted by complementary RNAseq analysis, we defined the fraction of the CPC proteome associable with specific functions by comparison with human bone marrow mesenchymal stem cells (MSC), the reference population for cell therapy, and human dermal fibroblasts (HDF), as a distant reference. Label-free proteomic analysis identified 526 proteins expressed differentially in CPC. iTRAQ analysis confirmed differential expression of a substantial proportion of those proteins in CPC relative to MSC, and systems biology analysis defined a clear overrepresentation of several categories related to enhanced angiogenic potential. The CPC plasma membrane compartment comprised 1,595 proteins, including a minimal signature of 167 proteins preferentially or exclusively expressed by CPC. CDH5 (VE-cadherin), OX2G (OX-2 membrane glycoprotein; CD200), GPR4 (G protein-coupled receptor 4), CACNG7 (calcium voltage-gated channel auxiliary subunit gamma 7) and F11R (F11 receptor; junctional adhesion molecule A; JAM-A; CD321) were selected for validation. Their differential expression was confirmed both in expanded CPC batches and in early stages of isolation, particularly when compared against cardiac fibroblasts. Among them, GPR4 demonstrated the highest discrimination capacity between all cell lineages analyzed., This study was supported by funding from the European Commission (HEALTH-2009_242038), and by grants to AB from the Spanish Ministry of Science and Innovation (SAF2012-34327; SAF2015-70882-R), the Research Program of the Comunidad Autónoma de Madrid (S2011/BMD-2420), the Instituto de Salud Carlos III (RETICS-RD12/0019/0018), and grants from the Portuguese Foundation for Science and Technology (PTDC/ BBB-BIO/1414) to PMA. iNOVA4Health - UID/Multi/04462/2013, fnancially supported by FCT/Ministério da Educação e Ciência, through national funds and co-funded by FEDER under the PT2020 Partnership Agreement is also acknowledged. JL Abad, I Palacios and LR Borlado were employees of Coretherapix; Coretherapix is part of Tigenix Group since July 2015.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Polμ deficiency increases resistance to oxidative damage and delays liver aging

  • Escudero, Beatriz
  • Lucas, Daniel
  • Albo, Carmen
  • Dhup, Suveera
  • Bacher, Jeff W.
  • Sánchez, Aránzazu
  • Fernández, Margarita
  • Rivera Torres, José
  • Carmona, Rosa M.
  • Fuster, Encarnación
  • Carreiro, Candelas
  • Bernad, Raquel
  • González, Manuel A.
  • Andrés, Vicente
  • Blanco, Luis
  • Roche, Enrique
  • Fabregat Romero, Isabel
  • Samper, Enrique
  • Bernad, Antonio
Polμ is an error-prone PolX polymerase that contributes to classical NHEJ DNA repair. Mice lacking Polμ (Polμ−/−) show altered hematopoiesis homeostasis and DSB repair and a more pronounced nucleolytic resection of some V(D)J junctions. We previously showed that Polμ−/− mice have increased learning capacity at old ages, suggesting delayed brain aging. Here we investigated the effect of Polμ−/− deficiency on liver aging. We found that old Polμ−/− mice (>20 month) have greater liver regenerative capacity compared with wt animals. Old Polμ−/− liver showed reduced genomic instability and increased apoptosis resistance. However, Polμ−/− mice did not show an extended life span and other organs (e.g., heart) aged normally. Our results suggest that Polμ deficiency activates transcriptional networks that reduce constitutive apoptosis, leading to enhanced liver repair at old age.